(Hypertension. 1999;34:724-728.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Sympathetic Activation in the Pathogenesis of Hypertension and Progression of Organ Damage
From Cattedra di Clinica Medica (G.M., G.G., C.G.), Università di Milano, Ospedale S. Gerardo, Monza, Istituto Auxologico Italiano (G.M., G.S.), and Centro di Fisiologia Clinica e Ipertensione (G.M., G.G.), IRCCS, Milano, Italy.
Correspondence to Prof Giuseppe Mancia, Clinica Medica, Ospedale S. Gerardo dei Tintori, Via Donizetti 106, Monza (Milan), Italy.
Abstract—Although animal models of hypertension have clearly shown that high blood pressure is associated with and is probably caused by an increase in sympathetic cardiovascular influences, a similar demonstration in humans has been more difficult to obtain for methodological reasons. There is now evidence, however, of increased sympathetic activity in essential hypertension. This article will review this evidence by examining data showing that plasma norepinephrine is increased in essential hypertension and that this is also the case for systemic and regional norepinephrine spillover, as well as for the sympathetic nerve firing rate in the skeletal muscle nerve district. Evidence will also be provided that sympathetic activation is a peculiar feature of essential hypertension, particularly in its early stages, with secondary forms of high blood pressure not usually characterized by an increased central sympathetic outflow. Humoral, metabolic, reflex, and central mechanisms are likely to be the factors responsible for the adrenergic activation characterizing hypertension, which may also promote the development and progression of the cardiac and vascular alterations that lead to hypertension-related morbidity and mortality, independent of blood pressure values. This represents the rationale for considering sympathetic deactivation one of the major goals of antihypertensive treatment.
Key Words: nervous system, sympathetic • hypertension, essential • hypertension, secondary • pressoreceptors • hypertrophy • norepinephrine
This article has been cited by other articles:
 |
|
 |
|
  G. Grassi Assessment of Sympathetic Cardiovascular Drive in Human Hypertension: Achievements and Perspectives Hypertension, October 1, 2009; 54(4): 690 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Fung, Y. Chen, M. S. Lipkowitz, R. M. Salem, V. Bhatnagar, M. Mahata, C. M. Nievergelt, F. Rao, S. K. Mahata, N. J. Schork, et al. Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis Nephrol. Dial. Transplant., September 10, 2009; (2009) gfp471v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Charkoudian and J. A. Rabbitts Sympathetic Neural Mechanisms in Human Cardiovascular Health and Disease Mayo Clin. Proc., September 1, 2009; 84(9): 822 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Hodges, D. N. Jackson, L. Mattar, J. M. Johnson, and J. K. Shoemaker Neuropeptide Y and neurovascular control in skeletal muscle and skin Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R546 - R555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-Q. Zhu, Y. Xu, L.-M. Zhou, Y.-H. Li, L.-M. Fan, W. Wang, X.-Y. Gao, and Q. Chen Enhanced cardiac sympathetic afferent reflex involved in sympathetic overactivity in renovascular hypertensive rats Exp Physiol, July 1, 2009; 94(7): 785 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Fung and D. T. O'Connor Complex Renal Traits: Role of Adrenergic Genetic Polymorphism J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1172 - 1174. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Simms, J. F. R. Paton, A. E. Pickering, and A. M. Allen Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension? J. Physiol., February 1, 2009; 587(3): 597 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, F. Arenare, D. Spaziani, and G. Mancia Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction Hypertension, February 1, 2009; 53(2): 205 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rosendorff The Chicken and the Egg: Sympathetic Nervous System Activity and Left Ventricular Diastolic Dysfunction Hypertension, February 1, 2009; 53(2): 108 - 109. [Full Text] [PDF]
|
|
|
|
 |
|
 N. E Straznicky, G. W Lambert, K. Masuo, T. Dawood, N. Eikelis, P. J Nestel, M. T McGrane, J. A Mariani, F. Socratous, R. Chopra, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome Am. J. Clinical Nutrition, January 1, 2009; 89(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, M. Bombelli, C. Cuspidi, R. Facchetti, G. Bolla, and G. Mancia Adrenergic, Metabolic, and Reflex Abnormalities in Reverse and Extreme Dipper Hypertensives Hypertension, November 1, 2008; 52(5): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Giannarelli, A. Virdis, F. De Negri, E. Duranti, A. Magagna, L. Ghiadoni, A. Salvetti, and S. Taddei Tissue-Type Plasminogen Activator Release in Healthy Subjects and Hypertensive Patients: Relationship With {beta}-Adrenergic Receptors and the Nitric Oxide Pathway Hypertension, August 1, 2008; 52(2): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Flaa, I. K. Eide, S. E. Kjeldsen, and M. Rostrup Sympathoadrenal Stress Reactivity Is a Predictor of Future Blood Pressure: An 18-Year Follow-Up Study Hypertension, August 1, 2008; 52(2): 336 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morisco, C. Marrone, V. Trimarco, S. Crispo, M. G. Monti, J. Sadoshima, and B. Trimarco Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression Cardiovasc Res, December 1, 2007; 76(3): 453 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tkac, S. F. P. Man, and D. D. Sin Review: Systemic consequences of COPD Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 47 - 59. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Mizuno, A. Kamiya, T. Kawada, T. Miyamoto, S. Shimizu, and M. Sugimachi Muscarinic potassium channels augment dynamic and static heart rate responses to vagal stimulation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1564 - H1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, F. Arenare, and G. Mancia Neurogenic Abnormalities in Masked Hypertension Hypertension, September 1, 2007; 50(3): 537 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Blankestijn SYMPATHETIC HYPERACTIVITY--A HIDDEN ENEMY IN CHRONIC KIDNEY DISEASE PATIENTS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S293 - S297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Burns, M. U. Sivananthan, S. G. Ball, A. F. Mackintosh, D. A.S.G. Mary, and J. P. Greenwood Relationship Between Central Sympathetic Drive and Magnetic Resonance Imaging-Determined Left Ventricular Mass in Essential Hypertension Circulation, April 17, 2007; 115(15): 1999 - 2005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-P. Li and H.-L. Pan Role of {gamma}-Aminobutyric Acid (GABA)A and GABAB Receptors in Paraventricular Nucleus in Control of Sympathetic Vasomotor Tone in Hypertension J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 615 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Perlini, I. Ferrero, G. Palladini, R. Tozzi, C. Gatti, M. Vezzoli, F. Cesana, M. B. Janetti, F. Clari, G. Busca, et al. Survival Benefits of Different Antiadrenergic Interventions in Pressure Overload Left Ventricular Hypertrophy/Failure Hypertension, July 1, 2006; 48(1): 93 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-P. Li and H.-L. Pan Plasticity of GABAergic control of hypothalamic presympathetic neurons in hypertension Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1110 - H1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Perlini, G. Palladini, I. Ferrero, R. Tozzi, S. Fallarini, A. Facoetti, R. Nano, F. Clari, G. Busca, R. Fogari, et al. Sympathectomy or Doxazosin, But Not Propranolol, Blunt Myocardial Interstitial Fibrosis in Pressure-Overload Hypertrophy Hypertension, November 1, 2005; 46(5): 1213 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Joseph, C. Porta, G. Casucci, N. Casiraghi, M. Maffeis, M. Rossi, and L. Bernardi Slow Breathing Improves Arterial Baroreflex Sensitivity and Decreases Blood Pressure in Essential Hypertension Hypertension, October 1, 2005; 46(4): 714 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Berg Increased counteracting effect of eNOS and nNOS on an {alpha}1-adrenergic rise in total peripheral vascular resistance in spontaneous hypertensive rats Cardiovasc Res, September 1, 2005; 67(4): 736 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Sudano, L. Spieker, C. Binggeli, F. Ruschitzka, T. F. Luscher, G. Noll, and R. Corti Coffee Blunts Mental Stress-Induced Blood Pressure Increase in Habitual but Not in Nonhabitual Coffee Drinkers Hypertension, September 1, 2005; 46(3): 521 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. G. Yap, T. Duong, M. Bland, M. Malik, C. Torp-Pedersen, L. Kober, S. J. Connolly, B. Marchant, and J. Camm Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials Eur. Heart J., July 2, 2005; 26(14): 1385 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morisco, G. Condorelli, V. Trimarco, A. Bellis, C. Marrone, G. Condorelli, J. Sadoshima, and B. Trimarco Akt Mediates the Cross-Talk Between {beta}-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes Circ. Res., February 4, 2005; 96(2): 180 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension Hypertension, December 1, 2004; 44(6): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Gironacci, M. S. Valera, I. Yujnovsky, and C. Pena Angiotensin-(1-7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats Hypertension, November 1, 2004; 44(5): 783 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Jackson, E. G. Noble, and J. K. Shoemaker Y1- and {alpha}1-receptor control of basal hindlimb vascular tone Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R228 - R233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Smith, J. F. M. Meaney, L. N. Graham, J. B. Stoker, A. F. Mackintosh, D. A. S. G. Mary, and S. G. Ball Relationship of neurovascular compression to central sympathetic discharge and essential hypertension J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1453 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Koomans, P. J. Blankestijn, and J. A. Joles Sympathetic Hyperactivity in Chronic Renal Failure: A Wake-up Call J. Am. Soc. Nephrol., March 1, 2004; 15(3): 524 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Huggett, E. M. Scott, S. G. Gilbey, J. B. Stoker, A. F. Mackintosh, and D. A.S.G. Mary Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension Circulation, December 23, 2003; 108(25): 3097 - 3101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Sved and J. C. Sved Plasticity of GABA function in the nucleus tractus solitarius in hypertension Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1272 - R1273. [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali, F. Mallamaci, G. Tripepi, F. A. Benedetto, S. Parlongo, S. Cutrupi, D. Iellamo, G. Bonanno, F. Rapisarda, P. Fatuzzo, et al. Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2611 - 2617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Davrath, Y. Goren, I. Pinhas, E. Toledo, and S. Akselrod Early autonomic malfunction in normotensive individuals with a genetic predisposition to essential hypertension Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1697 - H1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, C. Turri, G. Bolla, and G. Mancia Short-Versus Long-Term Effects of Different Dihydropyridines on Sympathetic and Baroreflex Function in Hypertension Hypertension, March 1, 2003; 41(3): 558 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y.H. Chan, L.-L. Wang, Y.-M. Chao, and S. H.H. Chan Downregulation of Basal iNOS at the Rostral Ventrolateral Medulla Is Innate in SHR Hypertension, March 1, 2003; 41(3): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H.H.T. Klein, G. Ligtenberg, P. L. Oey, H. A. Koomans, and P. J. Blankestijn Enalapril and Losartan Reduce Sympathetic Hyperactivity in Patients with Chronic Renal Failure J. Am. Soc. Nephrol., February 1, 2003; 14(2): 425 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Corti, C. Binggeli, I. Sudano, L. Spieker, E. Hanseler, F. Ruschitzka, W. F. Chaplin, T. F. Luscher, and G. Noll Coffee Acutely Increases Sympathetic Nerve Activity and Blood Pressure Independently of Caffeine Content: Role of Habitual Versus Nonhabitual Drinking Circulation, December 3, 2002; 106(23): 2935 - 2940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, R. Dell'Oro, G. Seravalle, G. Foglia, F. Q. Trevano, and G. Mancia Short- and Long-Term Neuroadrenergic Effects of Moderate Dietary Sodium Restriction in Essential Hypertension Circulation, October 8, 2002; 106(15): 1957 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Smith, L. N. Graham, A. F. Mackintosh, J. B. Stoker, and D. A. S. G. Mary Sympathetic neural mechanisms in white-coat hypertension J. Am. Coll. Cardiol., July 3, 2002; 40(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali, F. Mallamaci, G. Tripepi, S. Parlongo, S. Cutrupi, F. A. Benedetto, A. Cataliotti, and L. S. Malatino Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease Hypertension, July 1, 2002; 40(1): 41 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali, F. Mallamaci, S. Parlongo, S. Cutrupi, F. A. Benedetto, G. Tripepi, G. Bonanno, F. Rapisarda, P. Fatuzzo, G. Seminara, et al. Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease Circulation, March 19, 2002; 105(11): 1354 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. H. T. KLEIN, G. LIGTENBERG, P. L. OEY, H. A. KOOMANS, and P. J. BLANKESTIJN Sympathetic Activity Is Increased in Polycystic Kidney Disease and Is Associated with Hypertension J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2427 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mancia White coat effect. Innocuous or adverse phenomenon? Eur. Heart J., October 2, 2000; 21(20): 1647 - 1648. [PDF]
|
|